| http://dbpedia.org/ontology/abstract
|
Celgene Corporation is a pharmaceutical co … Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS). subsidiary of Bristol Myers Squibb (BMS).
, Celgene è una società biofarmaceutica amer … Celgene è una società biofarmaceutica americana, con sede centrale a Summit, nel New Jersey, e attività in diversi paesi. È completamente integrata: scopre, sviluppa e commercializza farmaci per il cancro e i disturbi infiammatori. Il prodotto principale dell'azienda è Revlimid (lenalidomide), in associazione con desametasone per il trattamento di pazienti affetti da mieloma multiplo. La società è stata acquisita da Bristol-Myers Squibb nel 2019. È quotata al NASDAQ.yers Squibb nel 2019. È quotata al NASDAQ.
, شركة سلجين ( بالاتجليزية: Celgene Corporat … شركة سلجين ( بالاتجليزية: Celgene Corporation) شركة تأسست في ولاية ديلاوير ومقرها الرئيسي في سوميت ، نيو جيرسي ،تطور الأدوية الخاصة بالسرطان والالتهابات الالتهابية وتطورها وتسويقها. المنتج الرئيسي للشركة هو ليناليدوميد، بالاشتراك مع ديكساميثازون لعلاج العديد من مرضى المايلوما . الموافقة Revlimid أيضا في الولايات المتحدة لعلاج المرضى الذين يعانون من التي تعتمد على نقل الدم وفقر الدم ، ويرجع ذلك إلى البلدان المنخفضة أو المتوسطة-1-خطر متلازمة خلل التنسج النقوي (MDS) المرتبطة الحذف 5Q الشذوذ الوراثي الخلوي مع أو بدون إضافية الوراثية الخلوية تشوهات. يباع Revlimid من خلال برامج توزيع إدارة المخاطر الخاصة ، لضمان الاستخدام الآمن والمناسب لهذه الأدوية. تمت الموافقة على Vidaza لعلاج المرضى الذين يعانون من MDS. في نوفمبر 2019 ، أعلنت بريستول مايرز سكويب أنها أكملت استحواذها على شركة سلجين.سكويب أنها أكملت استحواذها على شركة سلجين.
, Celgene war ein US-amerikanisches Pharmaun … Celgene war ein US-amerikanisches Pharmaunternehmen, das sich auf die Herstellung von Arzneimitteln gegen Krebserkrankungen und Krankheiten des Immunsystems spezialisiert hatte. Der Sitz von Celgene befand sich in Summit, New Jersey. Das sich als biopharmaceutical company beschreibende Unternehmen beschäftigte rund 7.500 Mitarbeiter bei einem Umsatz von 15,3 Mrd. Dollar (2018). Celgene arbeitete in den Bereichen Hämatologie, Onkologie und inflammatorische Erkrankungen. Von Celgene entwickelte Immunmodulatoren, so genannte (Immunomodulatory Drugs), die ursprünglich vom Thalidomid-Molekül abgeleitet wurden, zielen auf die Bekämpfung der Krankheitsursachen, nicht auf die Symptome. Wichtigster Vertreter der IMiDs ist Lenalidomid zur Behandlung des multiplen Myeloms. Im Januar 2019 akzeptierte Celgene die Übernahme durch Bristol-Myers Squibb (BMS) für 74 Milliarden US-Dollar. Squibb (BMS) für 74 Milliarden US-Dollar.
, Clegene est une entreprise américaine spécialisée dans l’oncologie. Fondée en 1986 par Sol. J. Barrer, elle est issue d’une scission de Celanese. Elle est rachetée le 5 janvier 2019 par Bristol Myers Squibb.
, セルジーン・コーポレーション（英: Celgene Corporation）は、がんや炎症・免疫性疾患の領域における医療用医薬品の研究開発・販売を行うバイオテクノロジー企業。アメリカ合衆国・ニュージャージー州・Summitに本部を置き、世界30カ国以上で事業を展開している。ブリストル・マイヤーズ スクイブの完全子会社。日本法人はセルジーン株式会社。
, Celgene Corporation (NASDAQ: CELG) é uma empresa farmacêutica americana dedicada a Biotecnologia com fins de descobrir, desenvolver e comercializar medicamentos para o câncer e distúrbios inflamatórios, está sediada em Summit, Nova Jersey.
, 賽爾基因公司（Celgene Corporation），或譯新基公司，是一家總部位于美國新澤西州的生物科技公司，主要生產抗癌和消炎藥。
|
| http://dbpedia.org/ontology/assets
|
3.548E10
|
| http://dbpedia.org/ontology/equity
|
6.161E9
|
| http://dbpedia.org/ontology/foundingYear
|
1986
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/Robert_J._Hugin +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Summit%2C_New_Jersey +
|
| http://dbpedia.org/ontology/netIncome
|
4.046E9
|
| http://dbpedia.org/ontology/numberOfEmployees
|
8852
|
| http://dbpedia.org/ontology/parentCompany
|
http://dbpedia.org/resource/Bristol_Myers_Squibb +
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Abraxane +
, http://dbpedia.org/resource/Pomalyst +
, http://dbpedia.org/resource/Revlimid +
, http://dbpedia.org/resource/Thalomid +
, http://dbpedia.org/resource/Idhifa +
, http://dbpedia.org/resource/Imnovid +
|
| http://dbpedia.org/ontology/revenue
|
1.5281E10
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Celgene_logo.svg?width=300 +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.bms.com/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
2887610
|
| http://dbpedia.org/ontology/wikiPageLength
|
33104
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1118949017
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Multiple_myeloma +
, http://dbpedia.org/resource/Juno_Therapeutics +
, http://dbpedia.org/resource/Astrazeneca +
, http://dbpedia.org/resource/Fedratinib +
, http://dbpedia.org/resource/Dexmethylphenidate +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Crohn%27s_disease +
, http://dbpedia.org/resource/Lenalidomide +
, http://dbpedia.org/resource/Thalidomide +
, http://dbpedia.org/resource/Attention_deficit_hyperactivity_disorder +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_based_in_New_Jersey +
, http://dbpedia.org/resource/Otezla +
, http://dbpedia.org/resource/Category:Companies_based_in_Union_County%2C_New_Jersey +
, http://dbpedia.org/resource/Category:1980s_initial_public_offerings +
, http://dbpedia.org/resource/Pomalidomide +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Melphalan +
, http://dbpedia.org/resource/Delaware +
, http://dbpedia.org/resource/Apremilast +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Rahway_Valley_Railroad +
, http://dbpedia.org/resource/Heathrow_airport +
, http://dbpedia.org/resource/Chief_operating_officer +
, http://dbpedia.org/resource/Chief_Executive_Officer +
, http://dbpedia.org/resource/OncoMed +
, http://dbpedia.org/resource/Hoechst_AG +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Abraxane +
, http://dbpedia.org/resource/Bob_Hugin +
, http://dbpedia.org/resource/Executive_Chairman +
, http://dbpedia.org/resource/Chronic_myelomonocytic_leukemia +
, http://dbpedia.org/resource/False_Claims_Act +
, http://dbpedia.org/resource/United_Kingdom +
, http://dbpedia.org/resource/Dr._Reddy%27s_Laboratories +
, http://dbpedia.org/resource/Celanese +
, http://dbpedia.org/resource/Multiple_sclerosis +
, http://dbpedia.org/resource/Robert_J._Hugin +
, http://dbpedia.org/resource/Category:American_companies_established_in_1986 +
, http://dbpedia.org/resource/Linear_park +
, http://dbpedia.org/resource/Agios_Pharmaceuticals +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Windsor%2C_Berkshire +
, http://dbpedia.org/resource/Rail_trail +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Corporate_spin-off +
, http://dbpedia.org/resource/Biotech_and_pharmaceutical_companies_in_the_New_York_metropolitan_area +
, http://dbpedia.org/resource/Category:1986_establishments_in_New_Jersey +
, http://dbpedia.org/resource/Ulcerative_colitis +
, http://dbpedia.org/resource/United_States +
, http://dbpedia.org/resource/Sphingosine-1-phosphate_receptor_modulator +
, http://dbpedia.org/resource/Specialty_drugs +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Route_of_administration +
, http://dbpedia.org/resource/Azacitidine +
, http://dbpedia.org/resource/Starboard_Value +
, http://dbpedia.org/resource/Pharmaceutical_industry_in_Switzerland +
, http://dbpedia.org/resource/Category:2019_mergers_and_acquisitions +
, http://dbpedia.org/resource/Bristol_Myers_Squibb +
, http://dbpedia.org/resource/Melphalan_hydrochloride +
, http://dbpedia.org/resource/File:Celgene_logo.svg +
, http://dbpedia.org/resource/Pomalyst +
, http://dbpedia.org/resource/Revlimid +
, http://dbpedia.org/resource/Subsidiary +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1986 +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1986 +
, http://dbpedia.org/resource/Stem_cell_therapy +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/President_%28corporate_title%29 +
, http://dbpedia.org/resource/Chief_financial_officer +
, http://dbpedia.org/resource/Amgen +
, http://dbpedia.org/resource/Cytogenetic_abnormality +
, http://dbpedia.org/resource/Thalomid +
, http://dbpedia.org/resource/Idhifa +
, http://dbpedia.org/resource/Imnovid +
, http://dbpedia.org/resource/Category:Summit%2C_New_Jersey +
, http://dbpedia.org/resource/Category:Bristol_Myers_Squibb +
, http://dbpedia.org/resource/Novartis +
, http://dbpedia.org/resource/Dexamethasone +
, http://dbpedia.org/resource/Ozanimod +
, http://dbpedia.org/resource/Sutro_Biopharma +
, http://dbpedia.org/resource/Specialty_pharmacy +
, http://dbpedia.org/resource/Refractory_anemia +
, http://dbpedia.org/resource/Stockley_Park +
, http://dbpedia.org/resource/Demcizumab +
, http://dbpedia.org/resource/Forbes_magazine +
, http://dbpedia.org/resource/Summit%2C_New_Jersey +
|
| http://dbpedia.org/property/assets
|
3.548E10
|
| http://dbpedia.org/property/equity
|
6.161E9
|
| http://dbpedia.org/property/founder
|
Sol J. Barer
|
| http://dbpedia.org/property/homepage
|
https://www.bms.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
http://dbpedia.org/resource/Robert_J._Hugin +
, Mark Alles
|
| http://dbpedia.org/property/location
|
http://dbpedia.org/resource/Summit%2C_New_Jersey +
, http://dbpedia.org/resource/United_States +
|
| http://dbpedia.org/property/logo
|
150
|
| http://dbpedia.org/property/name
|
Celgene
, Celgene Corporation
|
| http://dbpedia.org/property/netIncome
|
4.046E9
|
| http://dbpedia.org/property/numEmployees
|
8852
|
| http://dbpedia.org/property/parent
|
http://dbpedia.org/resource/Bristol_Myers_Squibb +
|
| http://dbpedia.org/property/products
|
http://dbpedia.org/resource/Abraxane +
, http://dbpedia.org/resource/Thalomid +
, http://dbpedia.org/resource/Idhifa +
, http://dbpedia.org/resource/Imnovid +
, http://dbpedia.org/resource/Pomalyst +
, http://dbpedia.org/resource/Revlimid +
|
| http://dbpedia.org/property/revenue
|
1.5281E10
|
| http://dbpedia.org/property/secCik
|
CELG
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Subsidiary +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Finance_links_historical +
, http://dbpedia.org/resource/Template:Tree_list/end +
, http://dbpedia.org/resource/Template:Tree_list +
, http://dbpedia.org/resource/Template:Increase +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Decrease +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Portal +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Start_date_and_age +
|
| http://dbpedia.org/property/wordnet type
|
http://www.w3.org/2006/03/wn/wn20/instances/synset-company-noun-1 +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Pharmaceutical_companies_established_in_1986 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_established_in_1986 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_based_in_Union_County%2C_New_Jersey +
, http://dbpedia.org/resource/Category:Life_sciences_industry +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_based_in_New_Jersey +
, http://dbpedia.org/resource/Category:2019_mergers_and_acquisitions +
, http://dbpedia.org/resource/Category:American_companies_established_in_1986 +
, http://dbpedia.org/resource/Category:Orphan_drug_companies +
, http://dbpedia.org/resource/Category:Companies_formerly_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/Category:1986_establishments_in_New_Jersey +
, http://dbpedia.org/resource/Category:1980s_initial_public_offerings +
, http://dbpedia.org/resource/Category:Summit%2C_New_Jersey +
, http://dbpedia.org/resource/Category:Bristol_Myers_Squibb +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Company +
|
| http://www.w3.org/2004/02/skos/core#closeMatch
|
http://www.grid.ac/institutes/grid.418722.a +
, http://www.grid.ac/institutes/grid.476224.1 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Celgene?oldid=1118949017&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Celgene_logo.svg +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.bms.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Celgene +
|
| http://xmlns.com/foaf/0.1/name
|
Celgene Corporation
|
| owl:sameAs |
http://arz.dbpedia.org/resource/%D8%B3%D9%84%D8%AC%D9%8A%D9%86 +
, http://fa.dbpedia.org/resource/%D8%B3%D9%84%DA%98%D9%86 +
, http://www.wikidata.org/entity/Q842947 +
, http://sw.cyc.com/concept/Mx4rvZdBy5wpEbGdrcN5Y29ycA +
, http://it.dbpedia.org/resource/Celgene +
, http://azb.dbpedia.org/resource/%D8%B3%D9%84%DA%98%D9%86 +
, http://rdf.freebase.com/ns/m.0898kv +
, http://et.dbpedia.org/resource/Celgene +
, http://pt.dbpedia.org/resource/Celgene +
, http://fi.dbpedia.org/resource/Celgene +
, http://zh.dbpedia.org/resource/%E8%B3%BD%E7%88%BE%E5%9F%BA%E5%9B%A0 +
, http://ar.dbpedia.org/resource/%D8%B3%D9%84%D8%AC%D9%8A%D9%86 +
, http://fr.dbpedia.org/resource/Celgene +
, http://yago-knowledge.org/resource/Celgene +
, http://dbpedia.org/resource/Celgene +
, https://global.dbpedia.org/id/4zwL3 +
, http://de.dbpedia.org/resource/Celgene +
, http://ja.dbpedia.org/resource/%E3%82%BB%E3%83%AB%E3%82%B8%E3%83%BC%E3%83%B3 +
|
| rdf:type |
http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://umbel.org/umbel/rc/Business +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Organization108008335 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/WikicatManufacturingCompaniesEstablishedIn1986 +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompanies +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompanies +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatCompaniesEstablishedIn1986 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Company +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQ-100Index +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInNewJersey +
, http://dbpedia.org/class/yago/WikicatBiotechnologyCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedStates +
, http://dbpedia.org/class/yago/WikicatCompaniesInTheNASDAQBiotechnologyIndex +
, http://dbpedia.org/class/yago/WikicatCompaniesBasedInUnionCounty%2CNewJersey +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
|
| rdfs:comment |
Celgene Corporation is a pharmaceutical co … Celgene Corporation is a pharmaceutical company that makes cancer and immunology drugs. Its major product is Revlimid (lenalidomide), which is used in the treatment of multiple myeloma, and also in certain anemias. The company is incorporated in Delaware, headquartered in Summit, New Jersey, and a subsidiary of Bristol Myers Squibb (BMS). subsidiary of Bristol Myers Squibb (BMS).
, Clegene est une entreprise américaine spécialisée dans l’oncologie. Fondée en 1986 par Sol. J. Barrer, elle est issue d’une scission de Celanese. Elle est rachetée le 5 janvier 2019 par Bristol Myers Squibb.
, 賽爾基因公司（Celgene Corporation），或譯新基公司，是一家總部位于美國新澤西州的生物科技公司，主要生產抗癌和消炎藥。
, شركة سلجين ( بالاتجليزية: Celgene Corporat … شركة سلجين ( بالاتجليزية: Celgene Corporation) شركة تأسست في ولاية ديلاوير ومقرها الرئيسي في سوميت ، نيو جيرسي ،تطور الأدوية الخاصة بالسرطان والالتهابات الالتهابية وتطورها وتسويقها. المنتج الرئيسي للشركة هو ليناليدوميد، بالاشتراك مع ديكساميثازون لعلاج العديد من مرضى المايلوما . الموافقة Revlimid أيضا في الولايات المتحدة لعلاج المرضى الذين يعانون من التي تعتمد على نقل الدم وفقر الدم ، ويرجع ذلك إلى البلدان المنخفضة أو المتوسطة-1-خطر متلازمة خلل التنسج النقوي (MDS) المرتبطة الحذف 5Q الشذوذ الوراثي الخلوي مع أو بدون إضافية الوراثية الخلوية تشوهات. يباع Revlimid من خلال برامج توزيع إدارة المخاطر الخاصة ، لضمان الاستخدام الآمن والمناسب لهذه الأدوية. تمت الموافقة على Vidaza لعلاج المرضى الذين يعانون من MDS.ى Vidaza لعلاج المرضى الذين يعانون من MDS.
, Celgene Corporation (NASDAQ: CELG) é uma empresa farmacêutica americana dedicada a Biotecnologia com fins de descobrir, desenvolver e comercializar medicamentos para o câncer e distúrbios inflamatórios, está sediada em Summit, Nova Jersey.
, Celgene è una società biofarmaceutica amer … Celgene è una società biofarmaceutica americana, con sede centrale a Summit, nel New Jersey, e attività in diversi paesi. È completamente integrata: scopre, sviluppa e commercializza farmaci per il cancro e i disturbi infiammatori. Il prodotto principale dell'azienda è Revlimid (lenalidomide), in associazione con desametasone per il trattamento di pazienti affetti da mieloma multiplo. La società è stata acquisita da Bristol-Myers Squibb nel 2019. È quotata al NASDAQ.yers Squibb nel 2019. È quotata al NASDAQ.
, セルジーン・コーポレーション（英: Celgene Corporation）は、がんや炎症・免疫性疾患の領域における医療用医薬品の研究開発・販売を行うバイオテクノロジー企業。アメリカ合衆国・ニュージャージー州・Summitに本部を置き、世界30カ国以上で事業を展開している。ブリストル・マイヤーズ スクイブの完全子会社。日本法人はセルジーン株式会社。
, Celgene war ein US-amerikanisches Pharmaun … Celgene war ein US-amerikanisches Pharmaunternehmen, das sich auf die Herstellung von Arzneimitteln gegen Krebserkrankungen und Krankheiten des Immunsystems spezialisiert hatte. Der Sitz von Celgene befand sich in Summit, New Jersey. Das sich als biopharmaceutical company beschreibende Unternehmen beschäftigte rund 7.500 Mitarbeiter bei einem Umsatz von 15,3 Mrd. Dollar (2018). Celgene arbeitete in den Bereichen Hämatologie, Onkologie und inflammatorische Erkrankungen. Von Celgene entwickelte Immunmodulatoren, so genannte (Immunomodulatory Drugs), die ursprünglich vom Thalidomid-Molekül abgeleitet wurden, zielen auf die Bekämpfung der Krankheitsursachen, nicht auf die Symptome. Wichtigster Vertreter der IMiDs ist Lenalidomid zur Behandlung des multiplen Myeloms.omid zur Behandlung des multiplen Myeloms.
|
| rdfs:label |
Celgene
, سلجين
, 賽爾基因
, セルジーン
|
